Effect of variable antidiabetic treatments strategy on oxidative stress markers in obese patients with T2DM.

Diabetol Metab Syndr · 2017 · PMC5444104 · PMID 28546831

Europe PMC DOI

hedged sentences

0.0440

closest p · 0.9× alpha

0.0440

boldest claim

The sentences

borderline significantP = 0.044actually significant

In addition, a significant reduction of the median oxLDLc [G2 (P = 0.002), G3 (P = 0.017) and G4 (P = 0.002)] and both oxLDL/LDLc and oxLDL/HDL [G2 (P = 0.009 & 0.001) and G4 (P = 0.018 & 0.002)] respectively was observed during follow up with a borderline significant reduction in G1 (P = 0.044) and G3 (P = 0.05) regarding oxLDLc and oxLDLc/HDLc respectively (Table 4 ).

also in 11,409 other papers

borderline significanceno p-value reported

A similar decrease of oxLDL was observed in all diabetic subgroups with borderline significance in those receiving metformin alone.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.